News

A novel approach for ensuring the virtually unlimited production of QS-21, the ‘Gold Standard’ adjuvant for improving vaccine efficacy, will be the subject of an upcoming presentation at the BIO CEO & Investor Digital Conference, starting February 16. Gaston Salinas,...

Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vaccine business subsidiary of SK Group, announced an expanded collaboration and license agreement. In addition to the already existing manufacturing arrangement, SK Bioscience...

Lonza announced today an expansion of its solid form selection services based at its Bend, OR (USA) site. The increased service capabilities and dedicated team complement previously established SimpliFiH® Solutions first-in-human services consisting of phase-appropriate drug substance and drug...

Hungary on Friday began innoculating its population with the Russian-made Sputnik V coronavirus vaccine. The vaccinations began in four hospitals in the country's capital Budapest, according to Chief Medical Officer, Cecilia Muller. Speaking during a news conference, Muller said around...

Pharma, biotech and cell & gene companies who use Werum PAS-X MES as well as those who are interested in the use of manufacturing IT and manufacturing intelligence to digitize their production are invited to Connext 2021 – the...

The University of Oxford has launched the first study of ChAdOx1 nCoV-19 Covid-19 vaccine in children and young adults. The single-blind, randomised phase II trial, launched along with three partner sites in London, Southampton and Bristol, will analyse the vaccine’s...

BioIVT, a leading provider of research models and services for drug and diagnostic development, introduced its COVID-19 Vaccination Panel, composed of pre- and post-vaccination serum or PBMC samples, to enable researchers to study blood donors’ vaccine-generated immune response. BioIVT has...